Free Trial
LON:BVXP

Bioventix (BVXP) Share Price, News & Analysis

Bioventix logo
GBX 2,497 +47.00 (+1.92%)
As of 04:48 AM Eastern

About Bioventix Stock (LON:BVXP)

Advanced

Key Stats

Today's Range
2,440
2,497
50-Day Range
2,300
2,795
52-Week Range
2,199
4,200
Volume
2,694 shs
Average Volume
7,348 shs
Market Capitalization
£130.47 million
P/E Ratio
1,685.80
Dividend Yield
0.06%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BVXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BVXP Stock News Headlines

Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.tc pixel
3 UK Dividend Stocks Offering Yields Up To 7.2%
3 top AIM stocks to consider buying before they recover
See More Headlines

BVXP Stock Analysis - Frequently Asked Questions

Bioventix's stock was trading at GBX 3,240 on January 1st, 2025. Since then, BVXP shares have decreased by 24.6% and is now trading at GBX 2,444.

Bioventix PLC (LON:BVXP) posted its quarterly earnings data on Monday, March, 31st. The biotechnology company reported $72.27 earnings per share (EPS) for the quarter. Bioventix had a trailing twelve-month return on equity of 69.09% and a net margin of 59.51%.

Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON).

Company Calendar

Last Earnings
3/31/2025
Today
9/23/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Cannabis
Current Symbol
LON:BVXP
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 1.48
Trailing P/E Ratio
1,650.01
Forward P/E Ratio
14.70
P/E Growth
N/A
Net Income
£8.12 million
Net Margins
59.51%
Pretax Margin
N/A
Return on Equity
69.09%
Return on Assets
54.07%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.42
Quick Ratio
5.50

Sales & Book Value

Annual Sales
£13.66 million
Price / Sales
9.35
Cash Flow
GBX 79.13 per share
Price / Cash Flow
30.89
Book Value
GBX 229.94 per share
Price / Book
10.63

Miscellaneous

Outstanding Shares
5,225,000
Free Float
N/A
Market Cap
£127.70 million
Optionable
Not Optionable
Beta
0.35
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:BVXP) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners